Tejara Capital LTD Kiniksa Pharmaceuticals, Ltd. Transaction History

Tejara Capital LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$17.63 - $21.74 $925,575 - $1.14 Million	-52,500 Reduced 55.18%	42,649 $841 Million
Q4 2023 Feb 12, 2024	BUY	$14.37 - $19.07 $864,341 - $1.15 Million	60,149 Added 171.85%	95,149 $1.67 Billion
Q3 2023 Nov 15, 2023	BUY	$13.62 - $20.2 $476,700 - $707,000	35,000 New	35,000 $608 Million
Q2 2023 Aug 11, 2023	SELL	$10.44 - $16.48 $152,100 - $240,097	-14,569 Reduced 30.04%	33,931 $478 Million
Q1 2023 May 12, 2023	BUY	$10.7 - $15.79 $518,949 - $765,815	48,500 New	48,500 $522 Million

1.89M

Ticker KNSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 34,470,400
Market Cap $844M
Description
Kiniksa Pharmaceuticals, Ltd., a biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical needs worldwide. Its product candidates include ARCALYST, an interleukin-1alpha and interleukin-1beta, for the treatm...

Get notified when there are updates to the investment portfolio of Tejara Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Tejara Capital LTD with notifications on news.